KPMG's views on the new public policy environment in the United States: The impact on pharmaceutical and medical device companies

According to KPMG, change in healthcare policy is inevitable under the Obama administration. There is much speculation as to whether widespread reform will be implemented by the new leadership and if so, how and when this will occur. This eight-page special explores the impact of the new U.S. political environment on the pharmaceutical and medical devices industries.

Download the report here.

Drug Marketing Blow Out: Eli Lilly Fined $1.5B

Eli Lilly has been fined the largest amount for marketing fraud in US History, for their “off-label promotion” of the drug Zyprexa. According to CNNMoney.com, The company had promoted the drug as a treatment for dementia, including Alzheimer’s dementia in elderly people - for which it was never approved, the statement said. The company pleaded guilty to one misdemeanor charge as part of the settlement, it said in a statement. The sum includes a criminal fine of $515 million, which the Justice Department called “largest criminal fine for an individual corporation ever imposed in a United States criminal prosecution.”
What do you think of this settlement? As a marketer, how would you have done things differently? Share with us here.